OPRX 📈 OPTIMIZERx - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US68401U2042
OPRX: Digital, Marketing, Solutions, Healthcare, Technology
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts. Web URL: https://www.optimizerx.com
Additional Sources for OPRX Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OPRX Stock Overview
| Market Cap in USD | 96m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception | 1996-10-22 |
OPRX Stock Ratings
| Growth 5y | -61.9% |
| Fundamental | -42.2% |
| Dividend | - |
| Rel. Strength Industry | -1363 |
| Analysts | 4.57/5 |
| Fair Price Momentum | 3.64 USD |
| Fair Price DCF | - |
OPRX Dividends
No Dividends PaidOPRX Growth Ratios
| Growth Correlation 3m | -80.7% |
| Growth Correlation 12m | -94.1% |
| Growth Correlation 5y | -45.2% |
| CAGR 5y | -14.06% |
| CAGR/Mean DD 5y | -0.26 |
| Sharpe Ratio 12m | -1.10 |
| Alpha | -103.04 |
| Beta | 1.56 |
| Volatility | 92.30% |
| Current Volume | 290.3k |
| Average Volume 20d | 335.3k |
What is the price of OPRX stocks?
As of December 22, 2024, the stock is trading at USD 4.91 with a total of 290,325 shares traded.
Over the past week, the price has changed by -1.60%, over one month by +11.09%, over three months by -37.69% and over the past year by -65.00%.
As of December 22, 2024, the stock is trading at USD 4.91 with a total of 290,325 shares traded.
Over the past week, the price has changed by -1.60%, over one month by +11.09%, over three months by -37.69% and over the past year by -65.00%.
Is OPTIMIZERx a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, OPTIMIZERx (NASDAQ:OPRX) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -42.18 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPRX as of December 2024 is 3.64. This means that OPRX is currently overvalued and has a potential downside of -25.87%.
Probably not. Based on ValueRay Fundamental Analyses, OPTIMIZERx (NASDAQ:OPRX) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -42.18 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPRX as of December 2024 is 3.64. This means that OPRX is currently overvalued and has a potential downside of -25.87%.
Is OPRX a buy, sell or hold?
OPTIMIZERx has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy OPRX.
OPTIMIZERx has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy OPRX.
- Strong Buy: 4
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for OPRX stock price target?
According to ValueRays Forecast Model, OPRX OPTIMIZERx will be worth about 4.1 in December 2025. The stock is currently trading at 4.91. This means that the stock has a potential downside of -17.31%.
According to ValueRays Forecast Model, OPRX OPTIMIZERx will be worth about 4.1 in December 2025. The stock is currently trading at 4.91. This means that the stock has a potential downside of -17.31%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 11.2 | 127.5% |
| Analysts Target Price | 15.7 | 219.8% |
| ValueRay Target Price | 4.1 | -17.3% |